VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 69 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,193,828 | -26.2% | 1,147,912 | 0.0% | 0.00% | – |
| Q2 2023 | $1,618,556 | -11.3% | 1,147,912 | 0.0% | 0.00% | – |
| Q1 2023 | $1,825,180 | +8.9% | 1,147,912 | 0.0% | 0.00% | – |
| Q4 2022 | $1,675,952 | -64.8% | 1,147,912 | +3.0% | 0.00% | – |
| Q3 2022 | $4,759,000 | +35.2% | 1,114,368 | +22.8% | 0.00% | – |
| Q2 2022 | $3,520,000 | -10.8% | 907,260 | +9.5% | 0.00% | – |
| Q1 2022 | $3,945,000 | -25.7% | 828,877 | -43.0% | 0.00% | – |
| Q4 2021 | $5,307,000 | -54.2% | 1,454,326 | +0.7% | 0.00% | – |
| Q3 2021 | $11,586,000 | -28.7% | 1,444,615 | +0.7% | 0.00% | – |
| Q2 2021 | $16,261,000 | +745.2% | 1,433,922 | +589.2% | 0.00% | – |
| Q1 2021 | $1,924,000 | – | 208,048 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $1,232,000 | 0.82% |
| Samsara BioCapital, LLC | 689,709 | $2,945,000 | 0.69% |
| BVF INC/IL | 3,614,662 | $15,435,000 | 0.64% |
| Rubric Capital Management LP | 994,801 | $4,248,000 | 0.21% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $153,000 | 0.06% |
| MAI Capital Management | 637,641 | $2,723,000 | 0.05% |
| Jasper Ridge Partners, L.P. | 92,939 | $397,000 | 0.03% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,500 | $88,000 | 0.02% |
| Ergoteles LLC | 132,636 | $566,000 | 0.02% |
| Laurion Capital Management LP | 698,000 | $2,980,000 | 0.02% |